Nexvet Biopharma plc
DelistedCIK 1618561fmd_1CW4B6NY9Q8TNW4EQWYES9FH5AManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2012 to Mar 31, 2017, 16 periods
Latest annual · FY2015
Millions- Total revenues
- 0
- Operating income
- (22)
- Net income
- (19)
- Free cash flow
- (20)
Latest quarter · Q3 FY2017
Millions- Operating income
- (7)
- Net income
- (6)
- Free cash flow
- (6)
Nexvet Biopharma plc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Operating income | -$22.2 million | -$20 million | 10-K 2016-09-02 · proof | |
| Net income | -$19.4 million | -$11.9 million | 10-K 2016-09-02 · proof | |
| Cash from operating activities | -$14.8 million | -$10.9 million | 10-K 2016-09-02 · proof | |
| Free cash flow | -$19.7 million | -$11.1 million | 10-K 2016-09-02 · proof | |
| Total assets | $40.3 million | $56.7 million | -28.8% | 10-K 2016-09-02 · proof |
| Total liabilities | $5.2 million | $3.1 million | +67.7% | 10-K 2016-09-02 · proof |
| Cash and cash equivalents | $31.5 million | $52 million | -39.5% | 10-K 2016-09-02 · proof |
- What was Nexvet Biopharma plc's operating income in fiscal 2016?
- Nexvet Biopharma plc reported operating income of -$22.2 million for fiscal 2016 (the year ended Jun 30, 2016), against -$20 million the year before. Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What was Nexvet Biopharma plc's net income in fiscal 2016?
- Nexvet Biopharma plc reported net income of -$19.4 million for fiscal 2016 (the year ended Jun 30, 2016), against -$11.9 million the year before. Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What was Nexvet Biopharma plc's cash from operating activities in fiscal 2016?
- Nexvet Biopharma plc reported cash from operating activities of -$14.8 million for fiscal 2016 (the year ended Jun 30, 2016), against -$10.9 million the year before. Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What was Nexvet Biopharma plc's free cash flow in fiscal 2016?
- Nexvet Biopharma plc reported free cash flow of -$19.7 million for fiscal 2016 (the year ended Jun 30, 2016), against -$11.1 million the year before. Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What are Nexvet Biopharma plc's total assets?
- As of Jun 30, 2016, Nexvet Biopharma plc reported total assets of $40.3 million, against $56.7 million a year earlier (-28.8%). Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What are Nexvet Biopharma plc's total liabilities?
- As of Jun 30, 2016, Nexvet Biopharma plc reported total liabilities of $5.2 million, against $3.1 million a year earlier (+67.7%). Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
- What are Nexvet Biopharma plc's cash and cash equivalents?
- As of Jun 30, 2016, Nexvet Biopharma plc reported cash and cash equivalents of $31.5 million, against $52 million a year earlier (-39.5%). Source: the 10-K filed with the SEC on Sep 2, 2016. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1618561&period_type=annual&limit=5"Information only, not investment advice.